This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, S. J.
Right arrow Articles by Pearson, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, S. J.
Right arrow Articles by Pearson, L. D.

 Previous Article  |  Next Article 

J Virol, July 1998, p. 5599-5609, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

The Effects of Pharmacological and Lentivirus-Induced Immune Suppression on Orbivirus Pathogenesis: Assessment of Virus Burden in Blood Monocytes and Tissues by Reverse Transcription-In Situ PCR

Scott J. Brodie,1,2,* William C. Wilson,2 Patricia M. O'Hearn,1 David Muthui,1 Kurt Diem,1 and Leonard D. Pearson3

Virology Division/Retrovirology Laboratory, University of Washington School of Medicine, Seattle, Washington 981441; Arthropod-Borne Animal Disease Research Laboratory, Agricultural Research Service, U.S. Department of Agriculture, Laramie, Wyoming 820712; and Department of Microbiology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado 805233

Received 28 January 1998/Accepted 31 March 1998

We investigated the effects of pharmacological and lentivirus-induced immunosuppression on bluetongue virus (BTV) pathogenesis as a mechanism for virus persistence and induction of clinical disease. Immunologically normal and immunosuppressed sheep were infected subcutaneously with BTV serotype 3 (BTV-3), a foreign isolate with unknown pathogenicity in North American livestock, and with North American serotype 11 (BTV-11). Erythrocyte-associated BTV RNA was detected earlier and at greater concentrations in sheep treated with immunosuppressive drugs. Similarly, viral RNA and infectious virus were detected in blood monocytes earlier and at higher frequency in immunosuppressed animals: as many as 1 in 970 monocytes revealed BTV RNA at peak viremia, compared to <1 in 105 monocytes from immunocompetent sheep. Animals infected with BTV-3 had a higher virus burden in monocytes and lesions of greater severity than those infected with BTV-11. BTV RNA was detected by in situ hybridization in vascular endothelial cells and cells of monocyte lineage, but only in tissues from immunocompromised animals, and was most abundant in animals infected with BTV-3. In contrast, reverse transcription-in situ PCR showed BTV RNA from both viral serotypes in high numbers of tissue leukocytes and vascular endothelial cells from both immunosuppressed and, to a lesser extent, immunocompetent animals. Collectively, these findings show that BTV infection is widely distributed during acute infection but replication is highly restricted in animals with normal immunity. These findings also suggest that in addition to virulence factors that define viral serotypes, immunosuppression could play a role in the natural history of orbivirus infection, allowing for higher virus burden, increased virus persistence, and greater potential for acquisition of virus by the arthropod vector.


* Corresponding author. Mailing address: University of Washington School of Medicine, Department of Laboratory Medicine, Vaccine/Virology Division, Room T293X, Seattle, WA 98195. Phone: (206) 685-6894. Fax: (206) 685-3639. E-mail: sjbrodie{at}u.washington.edu.


J Virol, July 1998, p. 5599-5609, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Hemati, B., Contreras, V., Urien, C., Bonneau, M., Takamatsu, H.-H., Mertens, P. P. C., Breard, E., Sailleau, C., Zientara, S., Schwartz-Cornil, I. (2009). Bluetongue Virus Targets Conventional Dendritic Cells in Skin Lymph. J. Virol. 83: 8789-8799 [Abstract] [Full Text]  
  • Georges, G. E., Storb, R., Bruno, B., Brodie, S. J., Thompson, J. D., Taranova, A. G., Zaucha, J. M., Little, M.-T., Zellmer, E., Moore, P. F., Gooley, T., Sale, G., Kiem, H.-P., Sandmaier, B. M., Lyons, R. M., Nash, R. A. (2001). Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes. Blood 98: 3447-3455 [Abstract] [Full Text]  
  • Pauk, J., Huang, M.-L., Brodie, S. J., Wald, A., Koelle, D. M., Schacker, T., Celum, C., Selke, S., Corey, L. (2000). Mucosal Shedding of Human Herpesvirus 8 in Men. NEJM 343: 1369-1377 [Abstract] [Full Text]  
  • Brodie, S. J. (2000). Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease. J. Leukoc. Biol. 68: 351-359 [Abstract] [Full Text]